2024 / 01

Next Paper
DOI: 10.24075/brsmu.2024.003
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Determining the diagnostic value of the markers of congenital metabolic disorders by chromatography–mass spectrometry

Mamedov IS1, Zolkina IV2, Sukhorukov VS3, Krapivkin AI1
About authors

1 Voino-Yasenetsky Scientific and Practical Center for Specialized Assistance to Children, Moscow, Russia

2 LLC Clinic of New Medical Technologies “ArchiMed”, Moscow, Russia

3 Research Center of Neurology, Moscow, Russia

Correspondence should be addressed: Irina V. Zolkina
Vavilova, 68, k. 2, Moscow, 119261, Russia; ur.liam@ari_anikloz

About paper

Author contribution: Mamedov IS — research idea; Mamedov IS, Zolkina IV — research methods and procedure, statistical data processing; Zolkina IV — manustript writing; Mamedov IS, Sukhorukov VS, Zolkina IV, Krapivkin AI — manuscript editing; Krapivkin AI — research management.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Pirogov Russian National Research Medical University (protocol № 94 dated 14 December 2009). All parents or caregivers of the subjects submitted the informed consent to participation in the study.

Received: 2024-01-11 Accepted: 2024-01-29 Published online: 2024-02-15
|
  1. Colby JM, Thoren KL. Applications of mass spectrometry in the clinical laboratory. In: Clarke W, Marzinke MA. Contemporary Practice in Clinical Chemistry (Fourth Edition). Academic press; 2020, p. 351–63. DOI: 10.1016/B978-0-12-815499-1.00021-1.
  2. Kilgore MB, Platis D, Lim T, Isenberg S, Pickens CA, Cuthbert C, et al. Development of a universal second-tier newborn screening LC–MS/MS Method for amino acids, lysophosphatidylcholines, and organic acids. Analytical Chemistry. 2023; 95 (6): 3187–94. DOI: 10.1021/acs.analchem.2c03098.
  3. Percenti L, Vickery GNC. Newborn Screening Follow-up. Med J. 2019; 80 (1): 37–414. DOI: 10.18043/ncm.80.1.37.
  4. Chace DH, Kalas T, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003: 49 (11): 1797–817. DOI: 10.1373/clinchem.2003.022178.
  5. Mueller P, Schulze A, Schindler I. Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clin Chim Acta. 2003; 327: 47–57. DOI: 10.1016/S0009-8981(02)00327-3.
  6. Rashed MS. Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chrom. 2001; 758 (1): 27–48. DOI: 10.1016/s0378-4347(01)00100-1.
  7. Zoppa M, Gallo L, Zacchello F, Giordano G. Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC-ESI-MS/MS. J Chromatogr. 2006; 831 (1–2): 267–73. DOI: 10.1016/j.jchromb.2005.12.015.
  8. Wong HB, Lim GS. Measures of diagnostic accuracy: sensitivity, specificity, PPV and NPV. Proceedings of Singapore Healthcare. 2011: 20 (4): 316–8. DOI: 10.1177/201010581102000411.
  9. Thomas LA. New era predicted for LC-MS in the clinical lab. Clinical OMICs. 2016; 3 (9): 12–15.
  10. Mamedov IS, Perevezencev OA, Zolkina IV, Vedenin AI, Moskaleva NE, Suhorukov VS, i dr. Bystraja diagnostika nasledstvennyh boleznej obmena veshhestv u detej. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta. 2010; (3): 57–61. Russian.
  11. Mamedov IS, Zolkina IV, Suhorukov VS. Diagnostika nasledstvennyh boleznej metabolizma u detej. Klinicheskaja laboratornaja diagnostika. 2011; 10: 20–21. Russian.
  12. Mamedov IS, Suhorukov VS, Zolkina IV, Savina MI, Nikolaeva EA. Ocenka mass-spektrometricheskih pokazatelej dlja differencial'noj diagnostiki nasledstvennyh narushenij obmena organicheskih kislot u detej. Rossijskij vestnik perinatologii i pediatrii. 2019; 64 (1): 61–67. Russian.
  13. Baranova PV. Organicheskie acidurii: osnovnye principy analiza organicheskih kislot metodom gazovoj hromatografii s massspektrometriej: uchebno-metodicheskoe posobie. M.: Triumf, 2023; 80 s. Russian.
  14. Hananeh T, Solaleh E, Shaghayegh H, Babak A, Negar R, Arezou D-M. The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults. Frontiers in Endocrinology. 2023 [cited 2023 Nov 29]; 14: [10 p.]. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2023.1058952/full DOI: 10.3389/fendo.2023.1058952.
  15. Gunther SH, Khoo CM, Tai E-S, et al. Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population. BMJ Open Diab Res Care. 2020 [cited 2023 Nov 29]; 8: e001315 [10 p.]. Available from: https://drc.bmj.com/content/bmjdrc/8/1/e001315.full.pdf DOI: 10.1136/bmjdrc-2020-001315.